List of centrally authorised products with safety-related changes to the product information

Human medicines European public assessment report (EPAR): Fubelv, etanercept, Status: Opinion

Opinion on medicine for use outside EU: Acoziborole Winthrop, acoziborole, Trypanosomiasis, African, 26/02/2026 Positive opinion

Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Status: Opinion

Human medicines European public assessment report (EPAR): Dazparda, insulin aspart, Status: Opinion

Human medicines European public assessment report (EPAR): mCOMBRIAX, Influenza,COVID-19 mRNA vaccine, Status: Opinion

Human medicines European public assessment report (EPAR): Ojemda, tovorafenib, Status: Opinion

Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Status: Opinion

Human medicines European public assessment report (EPAR): Palsonify, paltusotine, Status: Opinion

Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Status: Opinion